TY - JOUR AU - Lipsky, P. E. AU - van der Heijde, D. M. AU - St Clair, E. W. AU - Furst, D. E. AU - Breedveld, F. C. AU - Kalden, J. R. AU - Smolen, J. S. AU - Weisman, M. AU - Emery, P. AU - Feldmann, M. PY - 2000 DA - 2000// TI - Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200011303432202 DO - 10.1056/NEJM200011303432202 ID - Lipsky2000 ER - TY - JOUR AU - St Clair, E. W. AU - van der Heijde, D. M. AU - Smolen, J. S. AU - Maini, R. N. AU - Bathon, J. M. AU - Emery, P. AU - Keystone, E. AU - Schiff, M. AU - Kalden, J. R. AU - Wang, B. PY - 2004 DA - 2004// TI - Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20568 DO - 10.1002/art.20568 ID - St Clair2004 ER - TY - JOUR AU - Bendtzen, K. AU - Geborek, P. AU - Svenson, M. AU - Larsson, L. AU - Kapetanovic, M. C. AU - Saxne, T. PY - 2006 DA - 2006// TI - Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22214 DO - 10.1002/art.22214 ID - Bendtzen2006 ER - TY - JOUR AU - Radstake, T. R. AU - Svenson, M. AU - Eijsbouts, A. M. AU - van den Hoogen, F. H. AU - Enevold, C. AU - van Riel, P. L. AU - Bendtzen, K. PY - 2009 DA - 2009// TI - Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.092833 DO - 10.1136/ard.2008.092833 ID - Radstake2009 ER - TY - JOUR AU - Takeuchi, T. AU - Miyasaka, N. AU - Inoue, K. AU - Abe, T. AU - Koike, T. PY - 2009 DA - 2009// TI - Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study JO - Mod Rheumatol VL - 19 UR - https://doi.org/10.3109/s10165-009-0195-8 DO - 10.3109/s10165-009-0195-8 ID - Takeuchi2009 ER - TY - JOUR AU - Wolbink, G. J. AU - Voskuyl, A. E. AU - Lems, W. F. AU - de GE AU - Nurmohamed, M. T. AU - Tak, P. P. AU - Dijkmans, B. A. AU - Aarden, L. PY - 2005 DA - 2005// TI - Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis JO - Ann Rheum Dis VL - 64 UR - https://doi.org/10.1136/ard.2004.030452 DO - 10.1136/ard.2004.030452 ID - Wolbink2005 ER - TY - JOUR AU - Wolbink, G. J. AU - Vis, M. AU - Lems, W. AU - Voskuyl, A. E. AU - de GE AU - Nurmohamed, M. T. AU - Stapel, S. AU - Tak, P. P. AU - Aarden, L. AU - Dijkmans, B. PY - 2006 DA - 2006// TI - Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21671 DO - 10.1002/art.21671 ID - Wolbink2006 ER - TY - JOUR AU - Lie, E. AU - van der Heijde, D. AU - Uhlig, T. AU - Mikkelsen, K. AU - Kalstad, S. AU - Kaufmann, C. AU - Rodevand, E. AU - Kvien, T. K. PY - 2011 DA - 2011// TI - Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2011.152363 DO - 10.1136/ard.2011.152363 ID - Lie2011 ER - TY - JOUR AU - Kievit, W. AU - Adang, E. M. AU - Fransen, J. AU - Kuper, H. H. AU - van de Laar, M. A. AU - Jansen, T. L. AU - De Gendt, C. M. AU - de Rooij, D. J. AU - Brus, H. L. AU - Van Oijen, P. C. PY - 2008 DA - 2008// TI - The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2007.083675 DO - 10.1136/ard.2007.083675 ID - Kievit2008 ER - TY - JOUR AU - Tanaka, Y. AU - Takeuchi, T. AU - Mimori, T. AU - Saito, K. AU - Nawata, M. AU - Kameda, H. AU - Nojima, T. AU - Miyasaka, N. AU - Koike, T. PY - 2010 DA - 2010// TI - Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.121491 DO - 10.1136/ard.2009.121491 ID - Tanaka2010 ER - TY - JOUR AU - den Broeder, A. A. AU - van der Maas, A. AU - van den Bemt, B. J. PY - 2010 DA - 2010// TI - Dose de-escalation strategies and role of therapeutic drug monitoring of biologics in RA JO - Rheumatology (Oxford) VL - 49 UR - https://doi.org/10.1093/rheumatology/keq060 DO - 10.1093/rheumatology/keq060 ID - den Broeder2010 ER - TY - BOOK AU - van der Maas, A. AU - Kievit, W. AU - van den Bemt, B. J. AU - van den Hoogen, F. H. AU - Van Riel, P. C. AU - den Broeder, A. A. PY - 2012 DA - 2012// TI - Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study ID - van der Maas2012 ER - TY - JOUR AU - Pascual-Salcedo, D. AU - Plasencia, C. AU - Ramiro, S. AU - Nuno, L. AU - Bonilla, G. AU - Nagore, D. AU - Del Ruiz, A. A. AU - Martinez, A. AU - Aarden, L. AU - Martin-Mola, E. PY - 2011 DA - 2011// TI - Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis JO - Rheumatology (Oxford) VL - 50 UR - https://doi.org/10.1093/rheumatology/ker124 DO - 10.1093/rheumatology/ker124 ID - Pascual-Salcedo2011 ER - TY - JOUR AU - Ducourau, E. AU - Mulleman, D. AU - Paintaud, G. AU - Chu Miow, L. D. AU - Lauferon, F. AU - Ternant, D. AU - Watier, H. AU - Goupille, P. PY - 2011 DA - 2011// TI - Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases JO - Arthritis Res Ther VL - 13 UR - https://doi.org/10.1186/ar3386 DO - 10.1186/ar3386 ID - Ducourau2011 ER - TY - JOUR AU - Mulleman, D. AU - Meric, J. C. AU - Paintaud, G. AU - Ducourau, E. AU - Magdelaine-Beuzelin, C. AU - Valat, J. P. AU - Goupille, P. PY - 2009 DA - 2009// TI - Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis JO - Arthritis Res Ther VL - 11 UR - https://doi.org/10.1186/ar2867 DO - 10.1186/ar2867 ID - Mulleman2009 ER - TY - JOUR AU - Bartelds, G. M. AU - Krieckaert, C. L. AU - Nurmohamed, M. T. AU - van Schouwenburg, P. A. AU - Lems, W. F. AU - Twisk, J. W. AU - Dijkmans, B. A. AU - Aarden, L. AU - Wolbink, G. J. PY - 2011 DA - 2011// TI - Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up JO - JAMA VL - 305 UR - https://doi.org/10.1001/jama.2011.406 DO - 10.1001/jama.2011.406 ID - Bartelds2011 ER - TY - JOUR AU - Bland, J. M. AU - Altman, D. G. PY - 1999 DA - 1999// TI - Measuring agreement in method comparison studies JO - Stat Methods Med Res VL - 8 UR - https://doi.org/10.1191/096228099673819272 DO - 10.1191/096228099673819272 ID - Bland1999 ER - TY - JOUR AU - Rau, R. AU - Simianer, S. AU - van Riel, P. L. AU - van De Putte, L. B. AU - Kruger, K. AU - Schattenkirchner, M. AU - Allaart, C. F. AU - Breedveld, F. C. AU - Kempeni, J. AU - Beck, K. PY - 2004 DA - 2004// TI - Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate JO - Scand J Rheumatol VL - 33 UR - https://doi.org/10.1080/03009740410005467 DO - 10.1080/03009740410005467 ID - Rau2004 ER - TY - JOUR AU - van den Bemt, B. J. AU - den Broeder, A. A. AU - Wolbink, G. J. AU - Hekster, Y. A. AU - van Riel, P. L. AU - Benraad, B. AU - van den Hoogen, F. H. PY - 2011 DA - 2011// TI - Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study JO - BMC Musculoskelet Disord VL - 12 UR - https://doi.org/10.1186/1471-2474-12-12 DO - 10.1186/1471-2474-12-12 ID - van den Bemt2011 ER - TY - JOUR AU - Bakker, M. F. AU - Jacobs, J. W. AU - Verstappen, S. M. AU - Bijlsma, J. W. PY - 2007 DA - 2007// TI - Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility JO - Ann Rheum Dis VL - 66 ID - Bakker2007 ER - TY - JOUR AU - Mease, P. J. PY - 2010 DA - 2010// TI - Improving the routine management of rheumatoid arthritis: the value of tight control JO - J Rheumatol VL - 37 UR - https://doi.org/10.3899/jrheum.091064 DO - 10.3899/jrheum.091064 ID - Mease2010 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/13/184/prepub UR - http://www.biomedcentral.com/1471-2474/13/184/prepub ID - ref22 ER -